Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Ms. Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Teodora-Eliana Petcov at National University of Science and Technology POLITEHNICA Bucharest | Romania

Teodora Eliana Petcov is a driven biomedical researcher with a strong foundation in biomaterials, molecular biology, and nanotechnology. Passionate about innovation in drug delivery and regenerative medicine, she has already co-authored scientific publications in reputed journals. Her international internships, multidisciplinary skills, and involvement in EU-funded research projects underscore her commitment to advancing medical technologies. Teodora balances research excellence with volunteer leadership, contributing to both academic and community-driven initiatives. With a sharp analytical mind, hands-on lab experience, and cross-cultural exposure, she exemplifies the next generation of biomedical scientists focused on improving patient care through science and innovation.

Publication Profile 

Scopus

Education

Teodora holds a Bachelor’s degree in Medical Engineering from the Polytechnic University of Bucharest  with a focus on biomaterials and medical devices. She is currently pursuing her Master’s in Biocompatible Substances, Materials, and Systems at the National University of Science and Technology POLITEHNICA Bucharest. Her thesis explored the internalization of nano-sized devices in biological structures. She was a visiting student at “Horia Hulubei” Nuclear Institute and Floreasca Emergency Hospital. Her academic path is complemented by certifications in English  and psycho-pedagogical training, showcasing both technical expertise and educational versatility.

Experience 

Teodora has completed multiple research internships, including roles in molecular biology and materials science labs. She gained practical expertise in 3D bioprinting, SEM techniques, SolidWorks, and conducted advanced testing like DSC and DMA. She has contributed to projects at the National Institute of Physics and Nuclear Engineering, University of Campania in Italy, and worked on PNRR-funded research on bone regeneration and multiple myeloma. Additionally, she has volunteered extensively in cultural and scientific event organization, holding assistant coordinator roles in Zenezia and MED, where she honed human resources, leadership, and scientific communication skills.

Awards  

Teodora has been recognized for her academic excellence and community involvement from high school through higher education. She received top honors for her Bachelor’s thesis, was selected for the prestigious ROSE program, and presented at the “Info-Practic” National Symposium on artificial intelligence. She participated in EU-supported initiatives like ERASMUS+ “Be a Buddy, Not a Bully” and contributed to major national projects, including the ongoing PNRR-funded research on personalized bone regeneration. Her work on cutting-edge nanostructures and her leadership in volunteer networks demonstrate her well-rounded excellence and dedication to scientific and societal progress.

Research Focus 

Teodora focuses on biomedical applications of nanotechnology, with a keen interest in targeted drug delivery, biopolymeric material synthesis, and regenerative medicine. Her Master’s research and publications revolve around understanding how nanostructures interact with cellular systems to improve treatment precision in diseases like multiple myeloma. She also explores the use of 3D printed biomaterials and advanced materials characterization techniques (SEM, DSC, DMA). Her interdisciplinary research combines materials science, molecular biology, and bioengineering to design patient-specific, low-toxicity solutions, positioning her at the frontier of precision and personalized medicine.

Publication Top Notes

Title: Nanostructures: An Efficient Drug Delivery Platform for Therapy of Multiple Myeloma
Year: 2025

Conclusion

Teodora Eliana Petcov is a highly promising emerging researcher whose interdisciplinary approach, early scientific contributions, and strong practical expertise align closely with the vision of the Best Researcher Award. Her dedication to innovation in biomaterials, nanotechnology, and regenerative medicine showcases both depth and futuristic relevance.

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Prof Yilong Wang, Beijing Tiantan Hospital, Capital Medical University, China

Dr. Yilong Wang, Executive Vice President of Beijing Tiantan Hospital, Capital Medical University, is a distinguished neurologist and scientist. With an MD and PhD in Neurology, he has pioneered research in stroke and rare neurological disorders. Author of 301 impactful journal articles and holder of 12 patents, his innovative work spans drug delivery systems and precision medicine. Honored with the 2023 Paul Dudley White International Award, he has also authored several clinical neurology manuals. His cutting-edge contributions, including transcranial drug delivery devices, underscore his commitment to advancing global healthcare. 🌍📚

Publication Profile

google scholar

Academic and Professional Background

Professor Yilong Wang 🎓, an accomplished neurologist, earned his MBBS and MSc from North China University of Science and Technology, followed by an MD and PhD in Neurology from Capital Medical University. He completed postdoctoral training at the University of San Francisco 🌉. Currently serving as Executive Vice President and Chief Scientist at Beijing Tiantan Hospital 🏥, Prof. Wang has led groundbreaking research in stroke and rare neurological diseases 🧠. Over the past five years, he has published 72 high-impact papers 📄, holds 12 patents, and made significant strides in precision medicine and drug delivery systems 💊, earning prestigious accolades like the 2023 Paul Dudley White International Award 🏆.

Editorial Appointments

 Professor Yilong Wang 🧑‍⚕️ holds prominent editorial roles, serving as the Assistant Editor-in-Chief of Stroke & Vascular Neurology 📚, Deputy Editor-in-Chief of the Chinese Journal of Cerebrovascular Diseases 🧠, and as an editorial board member of the Chinese Journal of Stroke ✍️. His collaborative efforts extend to leading institutions, including the Frontier Medical Interdisciplinary and Translational Center at the National Center for Neurological Disorders 🌐 and the Beijing Brain Science and Brain-Inspired Research Center 🧬. These partnerships underscore his commitment to advancing neurological research and fostering innovation in cerebrovascular and brain science 🏥.

Professional Memberships

Professor Yilong Wang 🧑‍⚕️ plays key leadership roles in various prestigious organizations. He serves as Vice Chairman of the Expert Committee for the National Health Commission’s Million Disability Reduction Project 🌟, demonstrating his dedication to public health. Prof. Wang is also the Deputy Leader of the Youth Group of the 8th Committee of the Neurology Branch of the Chinese Medical Association 🧠. Additionally, he is the Executive Vice Chairman of the Youth Working Committee of the Chinese Stroke Association 💼 and Vice Chairman of the Cerebral Small Vessel Disease Branch of the Chinese Stroke Association 🩺, driving innovation in neurological care.

Areas of Research

Professor Yilong Wang 🧑‍⚕️ specializes in clinical and translational research on cerebrovascular diseases and rare neurological disorders 🧠, with a focus on interdisciplinary medical-engineering innovations ⚙️. His research includes precision medicine for ischemic stroke 🩺, developing technologies for accurate diagnosis and treatment. He pioneers innovative drug delivery systems 💊, utilizing skull bone marrow-dura-lymphatic pathways to bypass the blood-brain barrier for safe intracranial drug delivery. Prof. Wang also investigates the pathogenesis, diagnostics, and interventions for cerebral small vessel disease and rare neurological disorders 🌐. Additionally, he advances intelligent skull flaps, smart drug delivery systems, and brain-computer interfaces 🤖.

Contributions

Professor Yilong Wang 🧑‍⚕️, a renowned neurologist at Beijing Tiantan Hospital 🏥, has revolutionized stroke and rare neurological disease research 🧠. Over the past five years, he has published 72 high-impact papers in top journals like NEJM, JAMA, and BMJ 📄 and holds 12 patents, with 2 successfully translated into clinical applications 🌟. His innovations include extending the time window for dual antiplatelet therapy, developing drugs for microcirculation disorders, and pioneering skull-based drug delivery systems to bypass the blood-brain barrier 💊. Recipient of the 2023 Paul Dudley White International Award 🏆, Prof. Wang has advanced precision medicine and rare disease research, improving global patient care 🌍.

Research Focus

Professor Yilong Wang is a distinguished researcher focusing on neurology, particularly stroke epidemiology, prevention, and management, and the application of artificial intelligence (AI) in healthcare. His work spans from analyzing stroke prevalence in China to exploring treatment strategies, including antiplatelet therapies and real-world applications of AI in medical practice. With a robust emphasis on stroke prevention, outcomes, and treatment innovation, his contributions bridge advanced research and clinical practice. Wang’s research also addresses the broader implications of healthcare technologies, underscoring their transformative potential. 🧠💊📊

Publication Top Notes

Artificial intelligence in healthcare: past, present and future

Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack

Stroke in China: advances and challenges in epidemiology, prevention, and management

Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic

Rivaroxaban for stroke prevention after embolic stroke of undetermined source

Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study

Summer soil drying exacerbated by earlier spring greening of northern vegetation